Two Whistleblowers Cut Out Of $193M Endo Settlement

By Igor Kossov (June 24, 2014, 3:47 PM EDT) -- A Pennsylvania federal court ruled Monday that only one of three whistleblowers can take a portion of Endo Pharmaceuticals Inc.'s $193 million settlement with the U.S. Department of Justice over the off-label marketing of the pain-relief patch Lidoderm, saying only the first to file suit is entitled to the award.

Former Endo sales representative Peggy Ryan brought the alleged matter to the government's attention in 2005 and worked with the DOJ to help build the case against Endo that eventually led to the February settlement agreement, according to the court's decision. Max Weathersby, also an Endo sales rep, brought a separate...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!